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Purpose Little is known about whether mild aberrations in glucose metabolism, which are seen in overweight/obese subjects
(OW/OB) without impaired glucose tolerance, affect regulator control elements for blood pressure homeostasis. Methods
Hence, we measured in age-matched male subjects with normal weight (n = 16; BMI = 22.4 kg m−2) and OW/OB (n =
11; BMI = 28.6 kg m−2) continuous beat-to-beat blood pressure, heart rate, stroke volume, myocardial contractility and 
baroreflex sensitivity during a 30 min baseline and for 120 min after the ingestion of 75 g glucose dissolved in 300 mL 
tap water (OGTT). Blood samples for the assessment of plasma glucose and insulin were collected at baseline and every 
30 min after the drink and homeostatic model assessment of insulin resistance (HOMA-IR) was calculated.
Results At baseline, glucose (5.3 ± 0.4 SD vs 5.0 ± 0.4 mmol L−1; p = 0.01), insulin (7.4 ± 0.4 vs 3.7 ± 2.7 mU L −1; p =
0.02) a nd HOMA-IR (1.8 ± 1.3 vs 0.8 ± 0.6; p = 0.01) were significantly higher in subjects with OW/OB, but none
classified as having impaired glucose tolerance (plasma glucose levels < 7.8 mmol L−1 at 120 min post-OGTT) or 
hypertension (all < 130/80 mmHg at baseline). In response to the glucose drink, and in comparison to subjects with 
normal weight, we observed in subjects with OW/OB a trend towards increased plasma insulin levels (+7445 ± 4858 vs. 
+4968 ± 1924 mU h L−1; p = 0.08), which was not seen for blood glucose (p = 0.59). Moreover, subjects with OW/OB
showed impaired peripheral vaso-dilation, diminished heart rate and myocardial contractility responses but increased
peripheral pulse pressure (all p < 0.05). Conclusions Young male subjects with OW/OB, but without glucose intolerance or
hypertension, showed attenuated periph-eral vasodilation and diminished cardiac responses to a glucose drink.
Keywords Sugar · Insulin resistance · Obesity · Blood pressure
Introduction
Currently, cardiovascular diseases are the world’s leading 
cause of morbidity and mortality [1]. Although high blood 
pressure is the largest contributor to cardiovascular disease-
related mortality (40% of all deaths) [2], overweight and 
obesity are also signiﬁcant modiﬁable risk factors [3, 4]. 
On one hand, people with overweight and obesity often 
exhibit signs of impaired glucose metabolism, which can 
increase the risk of type 2 diabetes mellitus [5], whilst 
impaired glucose tolerance and type 2 diabetes mellitus are 
both major risk factors for cardiovascular diseases [6]. On 
the other hand, central abdominal obesity (i.e. the excess 
accumulation of body fat around visceral organs and in close 
proximity to the liver) might be a powerful candidate for 
increasing the risk of obesity-related hypertension [7].
In this context, it has recently been suggested that 
impaired glucose tolerance may adversely aﬀect the cardio-
vascular system by impairing glycaemic-induced blood pres-
sure regulation [8]. According to this postulation, alterations 
in glucose metabolism are characterized by elevated levels 
of insulin and raised sympathetic neural activity at rest [8, 
9], an additional surge in insulin secretion following glucose 
ingestion might then cause further stimulation in sympa-
thetic nerve activity with a potential impact on total periph-
eral resistance [8, 10]. This, in turn, may lead to diminished 
peripheral vasodilation that could adversely aﬀect blood 
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pressure regulation [8, 10]. However, and to the best of our 
knowledge, it is currently not known whether early stage 
aberrations in glucose metabolism, i.e. mild increases in 
fasting glucose and insulin blood levels, but before impaired 
glucose tolerance emerges, might adversely aﬀect regulatory 
control elements for blood pressure homeostasis.
We, therefore, investigated in young male Caucasian 
subjects with overweight/obesity (body mass index between 
25.0 and 34.9 kg m−2) and age-matched Caucasian subjects 
with normal weight (body mass index between 18.5 and 
24.9 kg m−2) hemodynamic and metabolic responses to a 
glucose drink. We hypothesized that subjects with over-
weight/obesity, but without impaired glucose tolerance, 
display altered glucose metabolism in response to a glucose 
drink, which consequently aﬀects hemodynamic regulation, 
characterized by a diminished vasodilatory eﬀect of insulin 




Taking data from a previously published study from our 
laboratory [11], we reanalysed data from 24 male Caucasian 
subjects (six were removed due to impaired glucose toler-
ance test) and added data from 3 unpublished obese male 
Caucasian subjects. Hence, we included 27 subjects in our 
ﬁnal analysis for the current paper. Subjects were students 
(and their friends) recruited from the university surround-
ings. Eligibility criteria included: Caucasian, male, healthy, 
non-smoker, 165–200 cm in height, 20–45 years old with a 
body mass index ranging from 18.5 to 34.9 kg m−2. Exclu-
sion criteria were as follows: individuals with pre-existing 
disease (i.e. arterial hypertension deﬁned by blood pressure 
values above 130/80 mmHg [12], type 2 diabetes deﬁned 
by fasting plasma glucose levels above 7.0 mmol L−1 [13]) 
or who were taking any medication aﬀecting cardiovascular 
regulation as well as competition athletes and individuals 
with a daily exercise workload exceeding 60 min per day. In 
addition, and after the analysis of the study results, subjects 
diagnosed with impaired glucose tolerance, based on the 
following criteria in response to the oral glucose tolerance 
test, were also excluded: showing either (a) fasting glucose 
levels ≥ 6.1 mmol L−1 (126 mg dL−1) [13], or (b) 2-h glu-
cose ≥ 7.8 mmol L−1 (140 mg dL−1) [13, 14]. This study 
was conducted according to the guidelines laid down in the 
Declaration of Helsinki and local ethical committee approval 
was obtained for all procedures involving human subjects. 
All subjects provided written consent prior to the start of 
the study.
Study design
All experiments took place in a quiet, temperature-con-
trolled (22 ± 1 °C) laboratory and began at 08.00 a.m. fol-
lowing a 12-h overnight fast. Subjects were requested to 
avoid alcohol, caﬀeine and physical activity for 24 h prior 
to the experiment, and to use public transportation to reach 
the laboratory. On arrival, subjects were asked to use the 
restroom if necessary and then to sit in a custom-made 
and comfortable chair. Electrocardiography and imped-
ance electrodes were positioned together with upper arm 
and blood pressure cuﬀs placed on the ﬁngers according to 
the manufacturer’s recommendations [11]. Then, the upper 
body was covered with a light blanket and an 18-gauge 
1.3 × 33-mm one-way Teﬂon catheter was inserted in the 
left cubital vein. This was followed by a variable period 
for attainment of cardiovascular stability, which was usu-
ally between 20 and 30 min. Then, baseline cardiovascular 
recordings were performed over a 30 min period, which 
was immediately followed by a baseline blood sample. 
The ingestion of the glucose drink [75 g of anhydrous 
D-glucose, dissolved in 300 mL water at room tempera-
ture (22 °C)], over 4 min, immediately followed the initial 
blood sample. Cardiovascular recordings then resumed and 
continued for another 120 min and blood samples were 
drawn every 30 min thereafter for up to 120 min post-
drink. In order to avoid boredom during the study [15], 
subjects watched calm documentaries on a television 
placed in front of them.
Cardiovascular measurements
Cardiovascular and hemodynamic parameters (systolic 
blood pressure, diastolic blood pressure, RR-interval 
(RRI), stroke volume, and the Heather index) were meas-
ured continuously using beat-to-beat equipment (Task 
Force Monitor, CNSystems, Medizintechnik, Graz, Aus-
tria), which generated data sampled at a rate of 1000 Hz 
and stored on a hard disc for later analysis [11, 16]. Con-
tinuous blood pressure monitoring followed the Penaz 
principle from either the index or middle ﬁnger of the 
right hand and was calibrated to oscillometric brachial 
blood pressure measurements on the contralateral arm 
without perturbations caused by the calibration signal 
[11]. This technique has been validated against invasive 
and continuous arterial measurements for its precision and 
accuracy [17] and provided an acceptable agreement dur-
ing normotensive conditions with interchangeable blood 
pressure recordings [18]. We used height-adjustable tables 
for reliable horizontally aligned placement of blood pres-
sure cuﬀs, i.e., table heights were adjusted to the height of 
the right atrium (forth-intercostal space), in order to avoid 











from heart level [11]. Moreover, an adaptive cushion was 
placed on top of each table where the subject’s forearms 
rested comfortably throughout the study [11]. Blood pres-
sure cuﬀ sizes were chosen according to the upper arm cir-
cumference [11]. Cardiac stroke volume and the Heather 
index (as a marker for positive inotropy of the heart) [19] 
were derived through impedance cardiography measure-







 and reﬂects the changes in 
impedance to the time in which they are performed from 
the electrical onset to the peak mechanical action [20]. 
Impedance cardiography, in which changes in thoracic 
impedance are converted to reﬂect changes in thoracic 
ﬂuid content/volume over time, were performed based on 
the original Kubicek approach [21], but using an improved 
estimate of thoracic volume [22]. Finally, we determined 
Baroreﬂex sensitivity from spontaneous ﬂuctuations in 
continuously recorded blood pressure and cardiac interval 
using the sequence technique [16, 23].
Anthropometric and body composition 
measurements
Standing height was measured using a mechanical column 
scale with integrated stadiometer (Seca model 709, Ham-
burg, Germany) and body weight using an electronic scale 
(Tanita Corporation, Amsterdam, The Netherlands) [11]. 
Body mass index was calculated as the ratio of weight (kg) 
and height squared  (m2), whilst body composition was meas-
ured as previously published by our group [11, 24] using 
two validate techniques: (a) multi-frequency bioelectrical 
impedance analyzer (BIA; Inbody 720, Biospace Co., Ltd, 
Seoul, Korea) for the assessment of total fat mass (kg), fat 
free mass (kg), and visceral fat mass  [cm3] [11] and (b) a 
dual-frequency BIA device (ViScan AB-140, Tanita) for the 
assessment of total trunk (abdominal) fat [%] [24]. The ViS-
can technique has been validated against magnetic resonance 
imaging for the prediction of abdominal fat percentage [25].
Blood sample measurement
Blood samples were collected and used to measure plasma 
glucose and insulin as described previously [11]. Brieﬂy, 
samples were collected in appropriate BD vacutainers (Bec-
ton, Dickinson Allschwil, Switzerland) and were processed 
and centrifuged according to the manufacturer’s instructions 
to separate plasma from whole blood. Aliquots were then 
stored in 2 ml cryovials and plasma samples for glucose 
analysis were immediately frozen and stored at − 80 °C, 
whilst plasma samples for the analysis of insulin were 
stored at − 20 °C. After thawing the samples, assays were 
performed according to the manufacturer’s instructions: (i) 
Glucose by the reference method with hexokinase Glucose 
HK Gen.3 (cobas c 501, Roche Diagnostics) and (ii) insulin 
by using an ELISA assay kit (Mercodia, Uppsala, Sweden). 
Phlebotomy and blood sample processing were carried out 
in accordance with institutional safety requirements for the 
handling of human biological specimens.
Data collection and processing
Beat-to-beat values of systolic blood pressure, diastolic 
blood pressure, heart rate, stroke volume and the Heather 
index were averaged every 30 min during baseline and every 
30 min during the 120 min post-drink period in order to 
match blood data. Overall changes were calculated as aver-
ages over the entire 120 min measurement period with base-
line values subtracted [11]. Pulse pressure was calculated as 
systolic minus diastolic blood pressure and heart rate was 
calculated from the appropriate RR-interval [11]. Cardiac 
output was computed as the product of stroke volume and 
heart rate, whilst total peripheral resistance was calculated 
as mean blood pressure/cardiac output [11].
Area under curve analysis by the trapezoid method was 
used to assess glucose-induced responses for glucose and 
insulin [11]. Homeostatic model assessment for insulin 
resistance (HOMA–IR) was calculated as [fasting glucose 
(mmol L−1) × fasting insulin (mIU L−1)]/22.5 [26].
Statistical analysis
Statistical analyses were performed using Statistix (version 
8.0, Analytical Software, St. Paul, MN, USA) and Graph-
Pad Prism (Version 6, GraphPad Software, Inc., La Jolla, 
USA) and all values are reported as mean ± standard devia-
tion (SD).
In order to elucidate potential diﬀerences between the 
two groups, we performed statistical analysis with a two-
factor mixed-design ANOVA with time as within-subject 
factor (i.e. baseline, 30, 60, 90 and 120 min) and the group-
ing as between-subject factor (i.e. overweight/obese versus 
normal weight subjects). Testing for normal distribution was 
performed using the D’Agostino & Pearson omnibus nor-
mality test and repeated measures ANOVA with Dunnett’s 
multiple comparison post hoc testing (for systolic blood 
pressure, diastolic blood pressure, pulse pressure, heart rate 
and stroke volume) or the Friedman test with Dunns post 
hoc testing (for cardiac output, total peripheral resistance, 
Heather index, and Baroreﬂex sensitivity) was used to test 
for changes over time from baseline levels whenever signiﬁ-
cant diﬀerences were observed from the two-factor mixed-
design ANOVA. All reported p-values were two-sided and 












Baseline characteristics of the study subjects
A total of 27 male subjects were included in this study, 
of which 16 were normal weight and 11 were overweight/
obese. Baseline anthropometric-, blood-, and cardiovas-
cular data prior to consuming the glucose drink are pre-
sented in Tables 1 and 2. Based on these data, none of 
the subjects could be classiﬁed as having type 2 diabetes 
or hypertension, and groups did not diﬀer based on age 
(Tables 1 and 2).
Compared to subjects with normal weight, subjects 
with overweight/obesity had signiﬁcantly greater body 
mass index, fat mass, fat free mass, visceral fat, trunk 
(abdominal) fat, glucose, insulin and HOMA-IR (all 
p < 0.05, Table  1). With the exception of the Heather 
index (higher in subjects with normal weight, p = 0.01), 
as a marker of myocardial contraction force [27–29], and 
baroreﬂex sensitivity (higher in subjects with overweight/
obesity, p = 0.03) no other hemodynamic parameter dif-
fered between the two groups at baseline (Table 2).
Glucose drink-induced hemodynamic changes
Figures 1, 2, 3 depict systolic-, diastolic-, and pulse pres-
sure as well as heart rate, total peripheral resistance, the 
Heather index, cardiac output, stroke volume and baroreﬂex 
sensitivity in response to a glucose drink as (i) time course 
(left panels, respectively) and as (ii) cumulative response 
equivalent to an area under the curve analysis (right panels, 
respectively).
Unlike in subjects with normal weight, those with over-
weight/obesity showed a signiﬁcant increase in systolic 
Table 1  Baseline 
anthropometric- and blood data 
for male subjects with normal 
weight (n = 16) and subjects 
with overweight/obesity (n = 11)
n number of subjects, SD Standard deviation, HOMA-IR homeostasis model assessment of insulin resist-
ance, Statistical analysis was performed using an unpaired student’s t Test and p < 0.05 was considered as a 
signiﬁcant diﬀerence
Variable Normal weight Range Overweight/obese Range p value
Mean ± SD Mean ± SD
Age, years 23.7 ± 3.1 20–30 24.2 ± 4.4 20–31 0.73
Height, cm 177 ± 6 168–191 181 ± 7 166–189 0.15
Weight, kg 69 ± 5 58–80 94 ± 16 71–119 < 0.005
Waist circumference, cm 79 ± 4 74–87 97 ± 10 82–114 < 0.005
Body mass index, kg ×   m−2 22.2 ± 1.6 19.2–24.4 28.7 ± 3.2 25.2–34.2 < 0.005
Body fat mass, kg 9.0 ± 2.7 4.5–15.2 24.4 ± 9.6 14.1–42.5 < 0.005
Body fat mass,  % 12.9 ± 3.4 6.3–18.3 25.0 ± 5.8 17.8–34.8 < 0.005
Body fat free mass, kg 61 ± 6 49–70 70 ± 8 57–81 < 0.005
Visceral fat  cm3 47 ± 16 21–76 103 ± 36 44–175 < 0.005
Trunk fat  % 14.5 ± 4.2 5.0–22.3 28.5 ± 6.3 19.6–38.5 < 0.005
Glucose mmol  ×   L−1 5.0 ± 0.3 4.3–5.4 5.3 ± 0.4 4.7–5.9 0.01
Insulin mU  ×   L−1 3.7 ± 2.7 0.5–10.8 7.4 ± 4.9 2.6–17.5 0.02
HOMA-IR 0.8 ± 0.6 0.1–2.5 1.8 ± 1.3 0.6v4.6 0.01
Table 2  Baseline cardiovascular 
parameters for male subjects 
with normal weight (n = 16) 
and subjects with overweight/
obesity (n = 11)
n number of subjects, SD Standard deviation, Statistical analysis was performed using an unpaired students 
t-Test and p < 0.05 was considered as a signiﬁcant diﬀerence
Variable Normal weight Overweight/obese p value
Mean ± SD Mean ± SD
Systolic blood pressure, mm Hg 114 ± 7 113 ± 4 0.40
Diastolic blood pressure, mm Hg 73 ± 5 71 ± 5 0.28
Pulse pressure, mm Hg 42 ± 4 42 ± 4 0.88
Heart rate, beats  ×   min−1 66 ± 7 62 ± 7 0.17
Stroke volume, mL 79 ± 12 86 ± 17 0.24
Cardiac output, L ×   min−1 5.2 ± 0.7 5.2 ± 0.7 0.84
Total peripheral resistance, mm Hg  ×  min  ×   L−1 17.1 ± 2.6 16.5 ± 2.3 0.55
Heather index, 1  ×   sec−2 0.24 ± 0.04 0.20 ± 0.05 0.01











blood pressure (+1.5 ± 2.1 mmHg, p < 0.05) with unchanged 
diastolic blood pressure (Fig. 1, a and b, both panels), which 
lead to a signiﬁcant increase in postprandial pulse pressure 
that was diﬀerent from normal weight subjects (+2.6 ± 1.5 
versus +0.5 ± 1.4 mmHg, two-way mixed model ANOVA 
interaction eﬀect: p = 0.02; Fig. 1c, left and right panel).
Heart rate increased in response to the glucose drink in 
both groups, although to a lesser extent in subjects with 
Fig. 1  Left panels a–c Time 
course of changes (Δ) from 
baseline values over the fol-
lowing 30 min, 30–60 min, 
60–90 min and 90–120 min 
post-drink for systolic blood 
pressure (SBP), diastolic blood 
pressure (DBP) and pulse 
pressure (PP), respectively. $: 
Signiﬁcant interaction eﬀect 
between subjects with normal 
weight and subjects with over-
weight/obesity using two-way 
mixed model ANOVA analysis. 
Right panels represent individ-
ual mean changes in SBP, DBP 
and PP over 120 min post-drink, 
from which baseline values are 
subtracted. Left panel values 
are reported as mean ± stand-
ard deviation, whilst right 
panel data are presented as an 
individual scatter dot plot with 
a mean (bold horizontal lines 
indicate global mean changes 
derived from averaging all indi-
vidual mean changes). *p < 0.05 
and ***p < 0.005 statistically 
signiﬁcant diﬀerence when 












overweight/obesity than in subjects with normal weight 
(+2.9 ± 1.9 versus +4.5 ± 1.9 beats min−1, two-way mixed 
model ANOVA interaction eﬀect: p = 0.01; Fig. 2a, left 
and right panel). In subjects with overweight/obesity, 
glucose-induced peripheral vasodilation (total peripheral 
resistance: − 1.2 ± 1.3 vs. − 2.0 ± 0.6 mmHg min L−1, two-
way mixed model ANOVA interaction eﬀect: p = 0.04) and 
myocardial contractility (Heather index: +0.02 ± 0.03 vs. 
Fig. 2  Left panels a–c Time 
course of changes (Δ) from 
baseline values over the fol-
lowing 30 min, 30–60 min, 
60–90 min and 90–120 min 
post-drink for heart rate (HR), 
total peripheral resistance 
(TPR) and the Heather index 
(HI), respectively. $: Signiﬁ-
cant interaction eﬀect between 
subjects with normal weight 
and subjects with overweight/
obesity using two-way mixed 
model ANOVA analysis. Right 
panels represent individual 
mean changes in HR, TPR and 
HI over 120 min post-drink, 
from which baseline values are 
subtracted. Left panel values 
are reported as mean ± stand-
ard deviation, whilst right 
panel data are presented as an 
individual scatter dot plot with 
a mean (bold horizontal lines 
indicate global mean changes 
derived from averaging all indi-
vidual mean changes). *p < 0.05 
and ***p < 0.005 statistically 
signiﬁcant diﬀerence when 












+0.05 ± 0.02 s−2, two-way mixed model ANOVA interac-
tion eﬀect: p = 0.01) responses were signiﬁcantly impaired 
compared to subjects with normal weight (Fig. 2 b and c, 
left and right panels).
Stroke volume, cardiac output and baroreﬂex sensitivity 
did not diﬀer between the groups (all p > 0.10) (Fig. 3, a–c 
left and right panels).
Fig. 3  Left panels a–c Time 
course of changes (Δ) from 
baseline values over the fol-
lowing 30 min, 30–60 min, 
60–90 min and 90–120 min 
post-drink for stroke volume 
(SV), cardiac output (CO) and 
baroreﬂex sensitivity (BRS), 
respectively. Right panels rep-
resent individual mean changes 
in SV, CO and BRS over 
120 min post-drink, from which 
baseline values are subtracted. 
Left panel values are reported 
as mean ± standard deviation, 
whilst right panel data are 
presented as an individual scat-
ter dot plot with a mean (bold 
horizontal lines indicate global 
mean changes derived from 
averaging all individual mean 
changes.). *p < 0.05, **p < 0.01, 
and ***p < 0.005 statistically 
signiﬁcant diﬀerence when 












Glucose drink-induced changes in plasma glucose 
and insulin
In response to the glucose drink, subjects with over-
weight/obesity showed a trend toward greater cumulative 
insulin response compared to the normal weight group 
(+7445 ± 4858 vs. 4968 ± 1924 mU h L−1; p = 0.08) (Fig. 4 
b, right panel). In contrast, no signiﬁcant diﬀerence was 
observed between the groups for plasma glucose responses 
to the glucose drink (p = 0.59, Fig. 4 a, right panel).
Discussion
We investigated in young male subjects with overweight/
obesity, but without glucose intolerance or hypertension, and 
age-matched male subjects with normal weight whether mild 
aberrations in glucose metabolism caused by a glucose drink 
might aﬀect distinct regulatory control elements for blood 
pressure homeostasis. The present study shows that a mildly 
altered glucose metabolism (i.e. increased fasting glucose, 
insulin and HOMA-IR compared to the normal weight con-
trol group) already aﬀects the cardiovascular system and 
its homeostasis by attenuating peripheral vasodilation and 
diminishing cardiac responses after a glucose drink. More-
over, the subjects with overweight/obesity had increased 
pulse pressure in response to the glucose drink, a response 
that was not seen in subjects with normal weight.
Glucose metabolism represents one powerful factor 
capable of inducing short-term perturbations in peripheral 
resistance that are accompanied by changes in blood ﬂow. 
Indeed, seminal research shows that for individuals with nor-
mal glucose tolerance, who were in a resting state, insulin 
strongly stimulated the sympathetic nervous system, which 
emphasizes the impact of changes in plasma insulin levels 
on total peripheral resistance [9]. This contention was con-
ﬁrmed and extended by work from Baron and Brechtel [30], 
who showed that insulin primarily aﬀected skeletal muscle 
vascular resistance and, consequently, increased cardiac 
output dose-dependently [30]. Moreover, and in contrast 
to individuals with normal weight, vascular resistance and 
the accompanying increase in cardiac output was blunted 
in obese and insulin-resistant subjects [30]. However, it is 
currently unknown whether subjects with overweight/obe-
sity, but without glucose intolerance, also present signs of 
a perturbed vascular action of insulin in response to a glu-
cose drink. In comparison to our control group with nor-
mal weight, we observed in male subjects with overweight/
obesity, but without glucose intolerance, a signiﬁcantly 
impaired drop in total peripheral resistance in response to 
the glucose drink, which points toward a perturbation in the 
normal insulin-induced peripheral vasodilation. It could be 
Fig. 4  Left panels a and b Time 
course changes in absolute 
values for plasma glucose and 
plasma insulin, respectively. 
Left panels represent aver-
aged data from the respective 
blood-draw interval starting 
at baseline, denoted as 0, and 
every 30 min thereafter up to 
120 min. Right panels represent 
individual area under curve 
analysis using the trapezoid 
method for plasma glucose 
and plasma insulin measured 
over 120 min post-drink. Left 
panel values are reported as 
mean ± standard deviation, 
whilst right panel data are 
presented as an individual scat-
ter dot plot with a mean (bold 
horizontal lines indicate global 
mean changes derived from 
averaging all individual mean 
changes). *p < 0.05, **p < 0.01 
and ***p < 0.005 statistically 
signiﬁcant diﬀerence when 












speculated that our observed acute hemodynamic eﬀects 
are, at least in part, triggered by visceral intra-abdominal fat 
depots, which, according to the portal theory [31], adversely 
aﬀect hepatic and peripheral insulin resistance. Therefore, 
it is suggestible that repeated and frequent intake of sugary 
drinks, which increases the likeliness of developing general 
[32] and abdominal obesity [33], could over time promote 
the risk of developing type 2 diabetes and cardiovascular dis-
ease. Moreover, acutely increased insulin levels are known 
to elevate sympathetic nervous tone [9], which, in turn, over 
time might adversely aﬀect the salt sensitivity of the kidneys 
due to sympathetic overstimulation with the potential for 
blood pressure dysregulation [7].
Insulin-induced changes in cardiac output in response 
to the glucose drink were not observed to be different 
between our groups, whilst heart rate, but not stroke volume, 
increased in subjects with normal weight to a signiﬁcantly 
greater level compared to subjects with overweight/obesity. 
Moreover, a reduced myocardial contraction force accompa-
nied this attenuated heart rate response to the glucose drink 
seen in subjects with overweight/obesity. This latter ﬁnding 
is in agreement with a previous study, which investigated 
myocardial characteristics in subjects with severe obesity, 
overweight/obesity and normal weight that showed subclini-
cal changes of left ventricular function even in overweight 
(BMI: 25–29.9 kg m−2) and mildly obese subjects (BMI: 
30–35 kg m−2) [34].
In response to the glucose drink, the blood pressure 
results from the present study demonstrate evidence toward 
increasing pulse pressure values in subjects with over-
weight/obesity, whilst systolic and diastolic blood pressure 
responses did not diﬀer between groups. Although systolic 
blood pressure responses were not observed to be diﬀerent 
between our groups, subjects with overweight/obesity, but 
not subjects with normal weight, had signiﬁcantly increased 
systolic blood pressure over time. In agreement with our 
blood pressure ﬁndings stands a cross-sectional study, which 
found that in subjects with obesity increasing levels of body 
mass index were independently associated with decreas-
ing arterial compliance, i.e. which led to increases in pulse 
pressure [35]. However, we were not able to discern pulse 
pressure diﬀerences at baseline between subjects with over-
weight/obesity and normal weight. Therefore, it might be 
that a glucose drink induced a rise in plasma insulin, which 
was signiﬁcantly higher in subjects with overweight/obesity, 
and could adversely aﬀect pulse pressure. Moreover, pulse 
pressure is dependent on elastic properties of Windkessel 
vessels and has been known to adversely aﬀect cardiovascu-
lar outcomes [36], therefore underscoring the clinical impli-
cation of our study’s ﬁnding. Another contributor toward 
short-term blood pressure regulation is the baroreﬂex where 
its sensitivity is suggested to be adjustable in order to match 
physiological adaptions to various cardiovascular perturba-
tions [37]. In this context, we were not able to detect a diﬀer-
ence between our groups for glucose-drink induced changes 
in baroreﬂex sensitivity, which could be potentially due to 
the young age of our test subjects. Indeed, La Rovere and 
colleagues identiﬁed age and blood pressure as the strong-
est predictors of baroreﬂex sensitivity [38], of which aging 
was observed to be associated with a decrease in baroreﬂex 
sensitivity [39].
Study limitations and perspective: We acknowledge that 
in our study the number of subjects with overweight/obesity 
is rather small, therefore our ﬁndings and conclusions should 
be considered with caution. Moreover, we only investigated 
a deﬁned cohort (i.e. young male Caucasians), therefore it 
still needs to be determined whether our ﬁndings can be 
conﬁrmed in children and adolescents, as well as in women 
and ethnicities other than Caucasians.
It is becoming increasingly evident that the human gut 
microbiota, i.e. micro-organisms that colonize the gut, 
might aﬀect human metabolism [40], whilst its contribu-
tion towards the development of obesity and type 2 diabetes 
is currently not yet clear [41] and warrants further investi-
gation [42]. Interestingly, non-caloric sweeteners, but not 
glucose or sucrose, are capable of inducing glucose intoler-
ance by altering the gut microbiota in a mouse model, as 
well as in humans [43]. However, due to the low number 
of human subjects in this above- mentioned study (n = 7) 
[43] and the number of non-responders (three out of seven 
subjects showed unchanged glycaemic responses to a glu-
cose tolerance test [43]) it remains to be established whether 
artiﬁcially sweetened or sugar sweetened beverages might 
adversely aﬀect the gut microbiota, which would lead to 
dysregulation of glucose metabolism.
In conclusion, the current study sought to explore 
whether mild alterations in glucose metabolism, which are 
seen in healthy male subjects with overweight/obesity, but 
without glucose intolerance or hypertension, aﬀect regula-
tory control elements of blood pressure homeostasis. We 
have chosen a standardized glucose drink in order to provoke 
a perturbation of blood pressure regulation and observed, 
in comparison to a control group with normal weight, that 
male subjects with overweight/obesity showed attenuated 
peripheral vasodilation and diminished cardiac responses 
associated with impaired cardiac output and myocardial con-
tractility. Moreover, the increase in peripheral pulse pressure 
observed in subjects with overweight/obesity might indicate 
an early sign of a dysregulated blood pressure response to 
an oral glucose load. Finally, our results add to the grow-
ing scientiﬁc evidence that the combination of overweight/
obesity and sugar intake aﬀects the cardiovascular system 
adversely and may therefore contribute to increased cardio-
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